GESIS-Leibniz Institute for the Social Sciences, Mannheim, Germany.
Assessment. 2012 Mar;19(1):89-100. doi: 10.1177/1073191111429389. Epub 2011 Dec 6.
Using two clinical samples of patients, the presented studies examined the construct validity of the recently revised Anxiety Sensitivity Index-3 (ASI-3). Confirmatory factor analyses established a clear three-factor structure that corresponds to the postulated subdivision of the construct into correlated somatic, social, and cognitive components. Participants with different primary clinical diagnoses differed from each other on the ASI-3 subscales in theoretically meaningful ways. Specifically, the ASI-3 successfully discriminated patients with anxiety disorders from patients with nonanxiety disorders. Moreover, patients with panic disorder or agoraphobia manifested more somatic concerns than patients with other anxiety disorders and patients with nonanxiety disorders. Finally, correlations of the ASI-3 scales with other measures of clinical symptoms and negative affect substantiated convergent and discriminant validity. Substantial positive correlations were found between the ASI-3 Somatic Concerns and body vigilance, between Social Concerns and fear of negative evaluation and socially inhibited behavior, and between Cognitive Concerns and depression symptoms, anxiety, fear of negative evaluation, and subjective complaints. Moreover, Social Concerns correlated negatively with dominant and intrusive behavior. Results are discussed with respect to the contribution of the ASI-3 to the assessment of anxiety-related disorders.
利用两个患者的临床样本,本研究检验了最近修订的焦虑敏感指数-3(ASI-3)的结构效度。验证性因子分析确立了一个清晰的三因素结构,与假设的躯体、社会和认知相关成分的构建细分相对应。具有不同主要临床诊断的参与者在 ASI-3 分量表上以理论上有意义的方式彼此不同。具体而言,ASI-3 成功地区分了焦虑障碍患者与非焦虑障碍患者。此外,惊恐障碍或广场恐怖症患者比其他焦虑障碍患者和非焦虑障碍患者表现出更多的躯体担忧。最后,ASI-3 量表与其他临床症状和负性情绪的测量结果之间的相关性证实了其具有收敛和区分效度。ASI-3 的躯体担忧与身体警觉之间、社会担忧与负面评价恐惧和社交抑制行为之间、认知担忧与抑郁症状、焦虑、负面评价恐惧和主观抱怨之间存在显著的正相关。此外,社会关注与主导和侵入性行为呈负相关。结果在评估与焦虑相关障碍方面,讨论了 ASI-3 的贡献。
Assessment. 2011-12-6
J Anxiety Disord. 2012-1-14
Turk Psikiyatri Derg. 2011
J Anxiety Disord. 2006
Eat Disord. 2025-3-14
Sci Rep. 2024-2-22
Eur J Ageing. 2022-10-31
J Affect Disord. 2022-2-1